EFFICACY OF METHYLPHENIDATE EXTENDED-RELEASE CHEWABLE TABLETS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: OPEN-LABEL, DOSE-OPTIMIZATION PERIOD OUTCOMES

被引：0
|
作者：
Wigal, Sharon B. [1 ]
Childress, Ann Catherine [1 ]
Berry, Sally [1 ]
Belden, Heidi [1 ]
Chappell, Phillip B. [1 ]
Wajsbrot, Dalia [1 ]
Nagraj, Praneeta [1 ]
Abbas, Richat [1 ]
Palumbo, Donna R. [1 ]
机构：
[1] AVIDA Inc, 1600 Dove St,Ste 305, Newport Beach, CA 92660 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2016年 / 55卷 / 10期
关键词：
D O I：
10.1016/j.jaac.2016.09.202
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
4.7
引用
收藏
页码：S164 / S165
页数：3
相关论文
共 50 条
  • [31] Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder
    Spencer, Thomas J.
    Adler, Lenard A.
    McGough, James J.
    Muniz, Rafael
    Jiang, Hai
    Pestreich, Linda
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (12) : 1380 - 1387
  • [32] Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
    Huss, Michael
    Sikirica, Vanja
    Hervas, Amaia
    Newcorn, Jeffrey H.
    Harpin, Valerie
    Robertson, Brigitte
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1085 - 1101
  • [33] A pooled analysis evaluating extended-release dexmethylphenidate in children with attention-deficit/hyperactivity disorder
    Turnbow, J
    Lopez, F
    Muniz, R
    Pestreich, L
    [J]. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2005, 26 (06): : 470 - 471
  • [34] Increase in Menstrual Cycle Length Induced by Extended-Release Methylphenidate in an Adolescent with Attention-Deficit/Hyperactivity Disorder
    Mutlu, Caner
    Bahali, Kayhan
    Gunes, Hatice
    Adaletli, Hilal
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (09) : 860 - 861
  • [35] Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder:: An open label trial
    Iseri, E.
    Kilic, B. G.
    Senol, S.
    Karabacak, N. I.
    [J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2007, 29 (01): : 47 - 52
  • [36] Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study
    Pan, Pei-Yin
    Fu, An-Ting
    Yeh, Chin-Bin
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (10) : 682 - 689
  • [37] Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
    Akira Iwanami
    Kazuhiko Saito
    Masakazu Fujiwara
    Daiki Okutsu
    Hironobu Ichikawa
    [J]. BMC Psychiatry, 20
  • [38] Amphetamine extended-release oral suspension for attention-deficit/hyperactivity disorder
    Childress, Ann C.
    Chow, Heather
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (10) : 965 - 971
  • [39] Clonidine Extended-Release In Attention-Deficit Hyperactivity Disorder Profile Report
    Croxtall, Jamie D.
    [J]. CNS DRUGS, 2012, 26 (03) : 277 - 279
  • [40] Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
    van der Schans, Jurjen
    Kotsopoulos, Nikos
    Hoekstra, Pieter J.
    Hak, Eelko
    Postma, Maarten J.
    [J]. PLOS ONE, 2015, 10 (05):
12345